Neeta S, Upadya Madhusudan, Gosain Anuradha, Manissery Jesni Joseph
Department of Anesthesiology, Kasturba Medical College, Manipal University, Mangalore, Karnataka, India.
Department of Anesthesiology, Fortis Hospital, Mohali, Punjab, India.
Anesth Essays Res. 2015 May-Aug;9(2):149-54. doi: 10.4103/0259-1162.156287.
Hyperbaric bupivacaine along with either fentanyl or sufentanil as additive, has been widely used in spinal anesthesia. In the present study, we compared the analgesic effects of intrathecal fentanyl versus sufentanil combined with bupivacaine for surgical procedures over the abdomen and lower limbs.
This was randomized controlled study conducted in a tertiary care hospital attached to a medical school.
Sixty American Society of Anesthesiologists I and II patients were randomized into three groups by sealed envelope technique. Group 1 was to receive bupivacaine with fentanyl; group 2 to receive bupivacaine with sufentanil and group 3 to receive bupivacaine with saline (control), intrathecally. The parameters checked were hemodynamic changes, onset and duration of sensory block, duration of analgesia and maximal sensory level achieved.
The data collected were analyzed using χ2 test and paired Student's t-test.
The time taken for the onset of analgesia was longest in the control group followed by fentanyl group. The earliest onset of action of 9.35 ± 1.92 min was recorded in sufentanil group. Duration of sensory blockade and analgesia was longest for fentanyl group than the other groups. Adverse effects noted were more for sufentanil group but were self-limiting.
Fentanyl with bupivacaine produced prolonged analgesia and delayed two-segment regression and demonstrated reduced incidence of complications as compared with intrathecal sufentanil. As the quality of analgesia was complete and comparable, fentanyl emerges as a better option for analgesia and it is much economical too when compared to sufentanil.
高压布比卡因联合芬太尼或舒芬太尼作为添加剂,已广泛用于脊髓麻醉。在本研究中,我们比较了鞘内注射芬太尼与舒芬太尼联合布比卡因用于腹部和下肢手术的镇痛效果。
这是一项在一所医学院附属三级护理医院进行的随机对照研究。
采用密封信封技术将60例美国麻醉医师协会I级和II级患者随机分为三组。第1组接受布比卡因加芬太尼;第2组接受布比卡因加舒芬太尼,第3组接受布比卡因加生理盐水(对照组),均为鞘内注射。检查的参数包括血流动力学变化、感觉阻滞的起效时间和持续时间、镇痛持续时间以及达到的最大感觉平面。
收集的数据采用χ2检验和配对学生t检验进行分析。
对照组镇痛起效时间最长,其次是芬太尼组。舒芬太尼组记录到最早的起效时间为9.35±1.92分钟。芬太尼组感觉阻滞和镇痛的持续时间比其他组更长。舒芬太尼组观察到的不良反应较多,但为自限性。
与鞘内注射舒芬太尼相比,芬太尼与布比卡因联合使用可产生延长的镇痛效果,并延迟两个节段的消退,且并发症发生率降低。由于镇痛质量完整且相当,与舒芬太尼相比,芬太尼成为更好的镇痛选择,而且成本也低得多。